Phenotypes and Genotypes of Patients with Pantothenate Kinase-Associated Neurodegeneration in Asian and Caucasian Populations: 2 Cases and Literature Review

Phenotypes and Genotypes of Patients with Pantothenate Kinase-Associated Neurodegeneration in Asian and Caucasian Populations: 2 Cases and Literature Review

Objectives. Pantothenate kinase-associated neurodegeneration (PKAN) is a rare disease caused by pantothenate kinase 2 (PANK2, OMIM 606157) mutations. This study is aimed to investigate clinical presentations, pathologies, and genetics in patients with PKAN. Methods. Two patients with PKAN were repor...

Full description

Bibliographic Details
Main Authors:	Chih-Hong Lee, Chin-Song Lu, Wen-Li Chuang, Tu-Hsueh Yeh, Shih-Ming Jung, Chia-Ling Huang, Szu-Chia Lai
Format:	Article
Language:	English
Published:	Hindawi Limited 2013-01-01
Series:	The Scientific World Journal
Online Access:	http://dx.doi.org/10.1155/2013/860539

Similar Items

Atypical pantothenate kinase-associated neurodegeneration with variable phenotypes in an Egyptian family
by: Ali S. Shalash, et al.
Published: (2021-07-01)

Proposed Therapies for Pantothenate-Kinase-Associated Neurodegeneration
by: Suzanne Jackowski
Published: (2019-05-01)

Precision medicine in pantothenate kinase-associated neurodegeneration
by: Mónica Alvarez-Cordoba, et al.
Published: (2019-01-01)

Retinitis pigmentosa in pantothenate kinase-associated neurodegeneration
by: José Luiz Pedroso, et al.
Published: (2014-10-01)

A therapeutic approach to pantothenate kinase associated neurodegeneration
by: Lalit Kumar Sharma, et al.
Published: (2018-10-01)

Late Onset Atypical Pantothenate-Kinase-Associated Neurodegeneration
by: Natalie Diaz
Published: (2013-01-01)

Deep Brain Stimulation for Pantothenate Kinase-Associated Neurodegeneration
by: Pedro J. Garcia-Ruiz, et al.
Published: (2015-01-01)

Eye of the Tiger Sign in Pantothenate Kinase-Associated Neurodegeneration
by: S. Choayb, et al.
Published: (2021-01-01)

Pantothenate Kinase-Associated Neurodegeneration- Rare form of Neurodegeneration with Brain Iron Accumulation
by: Anitha Kini, et al.
Published: (2020-01-01)

Pantothenate kinase-associated neurodegeneration: Clinical aspects, diagnosis and treatments
by: Saeed Razmeh, et al.
Published: (2018-04-01)

Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration
by: Randall D. Marshall, et al.
Published: (2019-07-01)

Harmful Iron-Calcium Relationship in Pantothenate kinase Associated Neurodegeneration
by: Paolo Santambrogio, et al.
Published: (2020-05-01)

Clinical Heterogeneity of Atypical Pantothenate Kinase-Associated Neurodegeneration in Koreans
by: Jae-Hyeok Lee, et al.
Published: (2016-01-01)

Advances in inherited and clinical research of pantothenate kinase⁃associated neurodegeneration
by: Xiao⁃yuan LI, et al.
Published: (2012-06-01)

Novel Compound Heterozygous Mutations in the Pantothenate Kinase 2 Gene in a Korean Patient with Atypical Pantothenate Kinase Associated Neurodegeneration
by: Sung-Hyouk Kim, et al.
Published: (2009-05-01)

Case report: MR spectroscopy in pantothenate kinase-2 associated neurodegeneration
by: Umesh C Parashari, et al.
Published: (2010-07-01)

Case report: MR spectroscopy in pantothenate kinase-2 associated neurodegeneration
by: Parashari Umesh, et al.
Published: (2010-01-01)

A pilot trial of deferiprone in pantothenate kinase-associated neurodegeneration patients
by: Mohammad Rohani, et al.
Published: (2018-02-01)

Novel PANK2 mutation identified in patient with pantothenate kinase-associated neurodegeneration
by: Svetel Marina, et al.
Published: (2020-01-01)

Sleep in Genetically Confirmed Pantothenate Kinase-Associated Neurodegeneration: A Video-Polysomnographic Study
by: Maria Livia Fantini, et al.
Published: (2010-01-01)

Pantothenate kinase-associated neurodegeneration (Hallerworden–Spatze disease): clinical aspects, diagnosis, treatment (literature review and own data)
by: Yu. H. Antypkin, et al.
Published: (2021-10-01)

Exploring Yeast as a Study Model of Pantothenate Kinase-Associated Neurodegeneration and for the Identification of Therapeutic Compounds
by: Camilla Ceccatelli Berti, et al.
Published: (2021-12-01)

Compartmentalization of mammalian pantothenate kinases.
by: Adolfo Alfonso-Pecchio, et al.
Published: (2012-01-01)

Novel PANK2 mutation in the first Greek compound heterozygote patient with pantothenate-kinase-associated neurodegeneration
by: George P Paraskevas, et al.
Published: (2017-07-01)

Phenotypic expression and founder effect of PANK2 c.1583C>T (p.T528M) mutation in Serbian pantothenate kinase-associated neurodegeneration patients
by: Svetel Marina, et al.
Published: (2019-01-01)

Down regulation of the expression of mitochondrial phosphopantetheinyl-proteins in pantothenate kinase-associated neurodegeneration: pathophysiological consequences and therapeutic perspectives
by: Mónica Álvarez-Córdoba, et al.
Published: (2021-05-01)

Mitochondrial iron and energetic dysfunction distinguish fibroblasts and induced neurons from pantothenate kinase-associated neurodegeneration patients
by: Paolo Santambrogio, et al.
Published: (2015-09-01)

A novel homozygous variation in the PANK2 gene in two Persian siblings with atypical pantothenate kinase associated neurodegeneration
by: Amir Hasan Habibi, et al.
Published: (2019-03-01)

Induction of Neuron-Specific Degradation of Coenzyme A Models Pantothenate Kinase-Associated Neurodegeneration by Reducing Motor Coordination in Mice.
by: Stephanie A Shumar, et al.
Published: (2015-01-01)

A new in vivo model of pantothenate kinase-associated neurodegeneration reveals a surprising role for transcriptional regulation in pathogenesis.
by: Varun ePandey, et al.
Published: (2013-09-01)

Mutations in the pantothenate kinase of Plasmodium falciparum confer diverse sensitivity profiles to antiplasmodial pantothenate analogues.
by: Erick T Tjhin, et al.
Published: (2018-04-01)

Pilot trial on the efficacy and safety of pantethine in children with pantothenate kinase-associated neurodegeneration: a single-arm, open-label study
by: Xuting Chang, et al.
Published: (2020-09-01)

A variation in PANK2 gene is causing Pantothenate kinase-associated Neurodegeneration in a family from Jammu and Kashmir – India
by: Arshia Angural, et al.
Published: (2017-07-01)

Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models.
by: Daniel Elbaum, et al.
Published: (2018-01-01)

Erratum: A new in vivo model of pantothenate kinase-associated neurodegeneration reveals a surprising role for transcriptional regulation in pathogenesis
by: Frontiers in Neuroscience Editorial Office
Published: (2013-10-01)

The Case of a Patient with Pantothenate Kinase-Associated Neurodegeneration Presenting with a Prolonged History of Stuttering Speech and a Misdiagnosis of Parkinson’s Disease
by: Prashant A Natteru, et al.
Published: (2021-01-01)

Amelioration of Dystonic Opisthotonus in Pantothenate Kinase-Associated Neurodegeneration Syndrome with Absent “Eye-of-the-Tiger” Sign Following Bilateral Pallidal Deep Brain Stimulation
by: Abdul Aziz, Z., et al.
Published: (2019)

Structural Studies On Mycobacterium Tuberculosis Pantothenate Kinase (PanK)
by: Chetnani, Bhaskar
Published: (2011)

Changes in Cerebral Gray and White Matter in Patients with Pantothenate Kinase-Associated Neurodegeneration: A Long-Term Magnetic Resonance Imaging Follow-Up Study
by: Pedro Roa-Sanchez, et al.
Published: (2021-05-01)

Characterization of prokaryotic pantothenate kinase enzymes and the development of type-specific inhibitors
by: Koekemoer, Lizbe
Published: (2011)